Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

Share Price is delayed by 15 minutes
Get Live Data
289.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.138%)
Market Cap: £3.23b
EMG Live PriceLast checked at - London Stock Exchange

Intraday Man Share Chart

Directorate Change

19 Oct 2022 07:00

RNS Number : 3210D
Man Group plc
19 October 2022
 

Directorate Change

19 October 2022

Man Group plc (the "Company") announces the appointment of Alberto Musalem as a non-executive director of the Company and as a member of the Audit & Risk Committee and Remuneration Committee with effect from 1 November 2022.

John Cryan, Chair of Man Group, said:  "I am delighted to welcome Alberto to the Man Group Board. He brings extensive investment management experience, economic and public policy expertise and broad knowledge of capital markets and regulation. I am confident that Alberto will add significant value to Man Group and we look forward to working with him."

Alberto Musalem - previous experience

Alberto served as CEO and Co-CIO of Evince Asset Management LP (2018 - 2022), an investment manager which he co-founded. Prior to this, he served as Executive Vice President and Senior Advisor to the President at the Federal Reserve Bank of New York (2014 - 2017) where he led the Integrated Policy Analysis and the Emerging Markets and International Affairs Groups, and served on the Bank's Management Committee. Alberto held senior positions at Tudor Investment Corporation (2000 - 2013), including Managing Director, Partner, Global Head of Research, and member of the firm's Management Committee. He also served as an economist at the International Monetary Fund (1996 - 2000). 

Alberto is currently a director of Freddie Mac, a US federal home loan mortgage corporation founded by Congress, where he is a member of the Risk Committee, Operations and Technology Committee and Compensation and Human Capital Committee. He is a member of the Distinguished Advisory Group of the Integrity Council for the Voluntary Carbon Market, the Council on Foreign Relations, and the Economic Club of New York. He is also Adjunct Professor of Finance at Georgetown University's McDonough School of Business.

This announcement is made in compliance with the Company's obligations under Listing Rule 9.6.11R.

The Company confirms that no other disclosures are required pursuant to Listing Rule 9.6.13R.

 

Enquiries

Man Group

Communications

Georgiana Brunner

+44 20 7144 1000

media@man.com

 

Investor Relations

Karan Shirgaokar

+44 20 7144 1434

investor.relations@man.com

 

Company Secretary

Elizabeth Woods

+44 20 7144 1733

company.secretarial@man.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWONRUNURAAA
Date   Source Headline
5th Mar 20246:00 pmRNSTransaction in Own Shares
5th Mar 20247:00 amRNSShare buyback programme of up to $50million
1st Mar 20247:00 amRNSTotal Voting Rights
29th Feb 20241:17 pmGNWMan Group PLC : Form 8.3 - Ageas SA/NV
29th Feb 20247:00 amRNSFinancial Results For The Year Ended 31 Dec 2023
1st Feb 20247:00 amRNSTotal Voting Rights
5th Jan 20247:00 amRNSDirectorate Change
2nd Jan 20247:00 amRNSTotal Voting Rights
12th Dec 20235:06 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
19th Oct 20237:00 amRNSTrading Statement Q3 2023
2nd Oct 20237:00 amRNSTotal Voting Rights
13th Sep 202312:00 pmRNSDirectorate Change
7th Sep 20237:00 amRNSCompletion of Varagon Capital Partners acquisition
5th Sep 202312:45 pmRNSDirector/PDMR Shareholding
1st Sep 20239:30 amRNSInterim Dividend - Sterling Conversion Rate
1st Sep 20237:00 amRNSTotal Voting Rights
25th Aug 202311:15 amRNSDirectorate Change
21st Aug 20234:00 pmRNSDirector/PDMR Shareholding
1st Aug 20239:30 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSHalf year results for the period ended 30 June 23
6th Jul 20237:00 amRNSMan Group to acquire Varagon Capital Partners
3rd Jul 20237:00 amRNSTotal Voting Rights
14th Jun 20233:15 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSTotal Voting Rights
24th May 20233:50 pmRNSDirector/PDMR Shareholding
15th May 20235:40 pmRNSTransaction in Own Shares
12th May 20235:30 pmRNSTransaction in Own Shares
11th May 20236:02 pmRNSTransaction in Own Shares
11th May 20237:00 amRNSMan Group appoints next CEO
10th May 20235:41 pmRNSTransaction in Own Shares
9th May 20235:55 pmRNSTransaction in Own Shares
5th May 20235:52 pmRNSTransaction in Own Shares
5th May 202312:20 pmRNSResult of AGM
5th May 20239:00 amRNSFinal Dividend - Sterling Conversion Rate
2nd May 20237:00 amRNSTotal Voting Rights
26th Apr 20237:00 amRNSTrading Statement Q1 2023
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20236:00 pmRNSTransaction in Own Shares
29th Mar 20236:12 pmRNSTransaction in Own Shares
28th Mar 20235:50 pmRNSTransaction in Own Shares
28th Mar 20237:00 amRNSDirectorate Change
27th Mar 20235:48 pmRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTotal Voting Rights
24th Mar 20235:48 pmRNSTransaction in Own Shares
23rd Mar 20235:59 pmRNSTransaction in Own Shares
23rd Mar 202312:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:49 pmRNSTransaction in Own Shares
21st Mar 20235:38 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.